SCHEMBL28215355

SCHEMBL28215355

Nc1[c]c(F)cc(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145942 0.81
SCHEMBL147215 0.74
SCHEMBL26185856 0.74
SCHEMBL18639790 0.70
SCHEMBL29015455 0.70
SCHEMBL25177285 0.70
SCHEMBL29015550 0.65 POLB (0.34)
SCHEMBL15353271 0.65 HSD17B10 (0.32)
SCHEMBL2232172 0.64
SCHEMBL29221526 0.63 KDM1A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116947903-A Inhibitors of complement factors and uses thereof 安尼艾克松股份有限公司 2023-10-27 CN disclosed
CN-116261564-A Inhibitors of complement factors and uses thereof 安尼艾克松股份有限公司 2023-06-13 CN disclosed
CN-107922405-A Compound, preparation method and use with ERK kinase inhibiting activities 中国科学院上海药物研究所 2018-04-17 CN disclosed